红日药业(300026) - 2024 Q3 - 季度财报

Financial Performance - Revenue for Q3 2024 was CNY 1,444,836,208.51, a decrease of 3.61% compared to the same period last year[2] - Net profit attributable to shareholders was CNY 20,124,487.02, down 87.68% year-on-year[2] - Net profit excluding non-recurring items was CNY 20,786,026.36, a decline of 82.65% compared to the previous year[2] - Total operating revenue for the period was CNY 4,441,070,030.88, a decrease of 9.7% compared to CNY 4,922,434,322.11 in the previous period[18] - The company's net profit attributable to shareholders increased to CNY 4,907,017,033.19, compared to CNY 4,828,784,918.38 in the previous period, showing a growth of 1.6%[16] - The net profit for Q3 2024 was CNY 192.40 million, a decrease from CNY 511.96 million in the same period last year, representing a decline of approximately 62.5%[19] - Operating income for Q3 2024 was CNY 201.13 million, down from CNY 542.78 million year-over-year, reflecting a decrease of about 63.0%[19] - Total comprehensive income for Q3 2024 was CNY 190.89 million, compared to CNY 517.40 million in the same quarter last year, marking a decrease of around 63.1%[19] - The company’s total profit for Q3 2024 was CNY 201.92 million, a decrease from CNY 594.03 million in the same period last year, representing a decline of about 66.0%[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 11,371,585,596.76, a decrease of 3.92% from the end of the previous year[2] - The total assets of the company decreased to CNY 11,371,585,596.76 from CNY 11,835,031,507.96, a decline of about 3.9%[17] - The total liabilities decreased to CNY 2,411,058,647.54 from CNY 2,967,268,858.43, reflecting a reduction of approximately 18.7%[16] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 505,125,392.74, down 49.11% year-on-year[2] - Cash flow from operating activities for the current period was CNY 505.13 million, significantly lower than CNY 992.59 million in the previous year, indicating a decline of approximately 49.1%[20] - The company experienced a net cash outflow of CNY 505.06 million in Q3 2024, contrasting with a net increase of CNY 363.96 million in the same period last year[21] - The company reported cash outflows from financing activities of CNY 886.19 million, compared to CNY 922.78 million in the previous year, indicating a slight decrease of about 4.0%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 110,822[8] - The major shareholder Chengdu Xingcheng Investment Group holds 667,997,417 shares, representing 22.24% of the total shares[10] - The company’s major shareholder Li Zhuo holds 111,350,135 shares, representing 3.71% of the total shares[10] - As of the end of the reporting period, the total number of restricted shares was 240,731,655, with 93,897,153 shares released during the period[12] - The company has a total of 251,239,240 restricted shares at the beginning of the period, with 93,219,378 shares released during the period[12] - The company has a total of 83,389,568 new restricted shares added during the period[12] - The company has a total of 240,731,655 restricted shares remaining at the end of the reporting period[12] Investment and Financing - The company reported a significant decrease in other income, which was CNY 26,330,800, down 37.90% year-on-year due to reduced government subsidies[7] - The company’s short-term borrowings decreased by 52.07% to CNY 11,107,300[6] - The company’s construction in progress increased by 58.61% to CNY 85,814,600, primarily due to increased investment in production expansion projects[6] - The company reported a total of 6 billion RMB in bonds issued to professional investors, with a coupon rate of 3.78%[13] - The company successfully completed a full redemption of 6 million bonds on August 23, 2024, with the total redemption amount being 6 billion RMB[14] - The company’s financial risk is considered controllable after the bond redemption, ensuring normal business operations[14] Earnings Per Share - The company’s diluted earnings per share for the reporting period was CNY 0.01, down 80.00% year-on-year[2] - Basic and diluted earnings per share for Q3 2024 were both CNY 0.06, down from CNY 0.17 in the previous year, a decline of approximately 64.7%[19]